Rolfo, CHRISTIAN DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 3.907
EU - Europa 681
AS - Asia 338
SA - Sud America 5
OC - Oceania 2
AF - Africa 1
Totale 4.934
Nazione #
US - Stati Uniti d'America 3.904
IT - Italia 251
CN - Cina 192
SG - Singapore 87
FI - Finlandia 75
DE - Germania 69
GB - Regno Unito 65
IE - Irlanda 63
SE - Svezia 35
RU - Federazione Russa 31
RO - Romania 16
ES - Italia 14
BE - Belgio 13
IN - India 10
KR - Corea 10
TR - Turchia 9
FR - Francia 8
UA - Ucraina 7
IR - Iran 6
NL - Olanda 6
CH - Svizzera 5
GR - Grecia 5
HK - Hong Kong 5
JP - Giappone 4
CA - Canada 3
CL - Cile 3
CZ - Repubblica Ceca 3
RS - Serbia 3
UZ - Uzbekistan 3
AT - Austria 2
BR - Brasile 2
HR - Croazia 2
LB - Libano 2
LT - Lituania 2
PL - Polonia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
MC - Monaco 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 4.934
Città #
Fairfield 723
Ashburn 364
Woodbridge 355
Seattle 308
Chandler 307
Houston 303
Cambridge 275
Wilmington 258
Ann Arbor 167
Singapore 73
Palermo 69
Medford 67
Dublin 62
Altamura 51
Princeton 42
Nanjing 41
Des Moines 39
Lawrence 38
Twinsburg 32
New York 31
San Diego 27
Dearborn 25
Beijing 24
Santa Clara 24
Boardman 19
Nanchang 19
London 18
Ludwigshafen am Rhein 17
Redwood City 16
Shenyang 16
Phoenix 14
Brussels 13
Changsha 13
Helsinki 12
Hebei 11
Jinan 11
Tianjin 11
Tulsa 11
San Paolo di Civitate 10
Chicago 9
Jiaxing 9
Los Angeles 9
Milazzo 9
Rome 9
Izmir 8
Seongnam 8
Ningbo 7
Bremen 6
Kitzingen 6
Forest City 5
Madrid 5
Milan 5
Saint Petersburg 5
Zhengzhou 5
Barcelona 4
Guangzhou 4
Norwalk 4
Orange 4
Parma 4
Amsterdam 3
Detroit 3
Edinburgh 3
Hangzhou 3
Pune 3
Renton 3
Shanghai 3
Tappahannock 3
Tokyo 3
Washington 3
Absecon 2
Athens 2
Bangkok 2
Berlin 2
Catania 2
Central District 2
Chiswick 2
Dolovo 2
Durham 2
Falls Church 2
Frankfurt am Main 2
Genoa 2
Hong Kong 2
Hounslow 2
Islington 2
Kilburn 2
Kumar 2
Kunming 2
Messina 2
Moscow 2
Naples 2
Novokuznetsk 2
Prescot 2
Rootstown 2
San Francisco 2
Sector 6 2
Stuttgart 2
Taizhou 2
Utrecht 2
Zagreb 2
Zweidlen-Dorf 2
Totale 4.133
Nome #
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 190
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 183
Exosomes in semen: Opportunities as a new tool in prostate cancer diagnosis 179
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 171
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 168
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 162
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 161
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 159
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 152
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 150
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 148
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward 147
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 139
Multisciplinary management of patients with liver metastasis from colorectal cancer 137
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 136
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition 133
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 131
Cancer and the microbiome: Potential applications as new tumor biomarker 130
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 128
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 126
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… 123
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment 118
Exosomes as diagnostic and predictive biomarkers in lung cancer 117
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 115
Targeting angiogenesis in biliary tract cancers: An open option 114
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy 113
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis? 109
Improving extracellular vesicles visualization: From static to motion 109
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 108
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 107
Ramucirumab and its use in gastric cancer treatment 105
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 105
Effects of exosomes released by NSCLC cells on osteoclasts differentiation. 104
BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door? 102
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 100
Role of NSCLC exosomes in osteoclast differentiation 76
VIPoma and PPoma 75
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 71
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia cells 67
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 60
Indications for locoregional tumor therapies: CRC liver metastases 55
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 49
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 42
null 16
Liquid biopsy: a right tool in a right context? 11
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors 9
Totale 5.210
Categoria #
all - tutte 19.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.462 0 0 97 374 189 186 150 127 142 98 66 33
2020/2021756 62 27 50 56 65 69 52 66 53 132 69 55
2021/2022574 31 107 30 20 19 27 20 45 61 81 45 88
2022/2023811 73 168 36 112 83 122 29 61 66 3 39 19
2023/2024363 14 48 26 26 19 56 63 23 18 11 3 56
2024/2025138 11 69 58 0 0 0 0 0 0 0 0 0
Totale 5.210